Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s footer/site revision version has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than any study-specific information.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a metadata/version update and does not alter study data or content.SummaryDifference0.1%

- Check34 days agoChange DetectedNew milestone dates were added and older dates removed in the Study Record Dates section, updating the trial's projected completion timeline.SummaryDifference0.3%

- Check56 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. This appears to be an internal maintenance update with no changes to the study content or user-facing features.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.4.2 is now displayed and older notices about funding lapse and a previous revision (v3.4.1) were removed; this is a minor maintenance update that does not affect the study details or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.